Duesseldorf (ots) - - Organic revenue growth of 17.4% in the third quarter supported by continued strong demand for High Value Solutions - Organic adjusted EBITDA up 13.3% - Gerresheimer firmly on track to deliver on FY 2022 guidance Gerresheimer AG, a leading provider of healthcare & beauty solutions ...
Duesseldorf (ots) - - First-quarter revenue grew organically by 19.1% - Adjusted EBITDA up organically by 10.6% - Gerresheimer raises revenue guidance to double-digit growth for 2022 Gerresheimer AG, a leading provider of healthcare & beauty solutions and drug delivery systems for pharma, biotech and ...
Duesseldorf (ots) - - Gerresheimer’s first own IP autoinjector suitable for both small and large molecules enhances broad portfolio of solutions, medical devices and pharmaceutical primary packaging F - irst joint project of Gerresheimer and Midas ...
Duesseldorf (ots) - - Core business revenue shows third-quarter organic growth of 9.8 % - Strategic positioning as innovative provider of biotech, pharma and beauty solutions delivers results - Adjusted EBITDA margin in core business organically at 20.9 % in third quarter - Third-quarter adjusted earnings per share rise organically by 5.2 % - Guidance confirmed for the financial year 2021 Gerresheimer AG ...
Düsseldorf (ots) - - Organic Group revenue growth of 7.5 %, and 7.1 % in core business - Solutions for biotech drugs and high-value solutions continue to drive revenues increase - Organic adjusted EBITDA margin at 22.8 % in core business - Adjusted earnings per share up organically by 19.1 % to EUR 1.28 - Guidance confirmed for the financial year 2021 ...
Duesseldorf (ots) - - Organic revenue growth of 3.1 % in core business - Strong development in High Value Solutions: Focus on Biological Solutions pays off - Adjusted EBITDA increases organically by 7.0 % in core business - Adjusted earnings per share rise organically by 29.3 % to EUR 0.57 - Guidance confirmed for the financial year 2021 "We got off to a ...
Duesseldorf (ots) - At its meeting yesterday, the Supervisory Board of Gerresheimer AG extended the contract with CEO Dietmar Siemssen (57) to the end of October 2026. Dietmar Siemssen has been CEO of Gerresheimer AG since November 2018. “Dietmar Siemssen has put Gerresheimer on the growth path. His ...
Duesseldorf (ots) - – Transformation in full swing: Continuous focus on growth delivers first positive results – Fourth-quarter Group revenues rise to 403m Euro: 7.3 % organic growth in the core business – Fourth-quarter adjusted EBITDA up to 100m Euro; 6.5 % organic growth in the core business – Target range for the financial year 2020 reached ...
Duesseldorf (ots) - - Transformation into a growth value as innovation leader and solution provider - Gerresheimer presents strategy process formula G as an engine towards sustainable profitable growth - Over proportional growth will be achieved by expanding in high value solutions, digital applications and growth regions - Strategic investments in growth ...
Dusseldorf (ots) - · Third quarter on schedule · Group revenues EUR 349m; 2.1% organic revenue growth in core business · Adjusted EBITDA increases by 4.1% to EUR 75m · Significant improvement in free cash flow to EUR 38m · Strong fourth quarter 2020 expected · Guidance for 2020 confirmed Gerresheimer AG delivered profitable growth in its core business ...
Duesseldorf (ots) - - Implementation of growth strategy beginning to deliver results - Group revenues increase to EUR 363m with 4.6% organic growth in core business - 6.9% organic growth in adjusted EBITDA to EUR 84m - Impacts of pandemic under control; potential vaccination campaigns open opportunities for specialty glass vials - Revenue guidance for 2020 ...
Duesseldorf (ots) - Payment of a dividend of EUR 1.20 per share was approved at the virtual Annual General Meeting of Gerresheimer AG. "In 2019, we paved the way for profitable growth and achieved a substantial improvement in the Company's culture and dynamic. We are investing and working to grow our ...
Düsseldorf (ots) - Stevanato Group, SCHOTT, and Gerresheimer confirm the readiness to support future Covid-19 Vaccine with pharmaceutical containers The CEOs of Gerresheimer, Stevanato Group, and SCHOTT are committed to ensuring ample supply of pharmaceutical containers for any Covid-19 vaccine and ...
Duesseldorf (ots) - - Stable business model as key supplier to pharma and healthcare industry - Gerresheimer sustains growth path. Revenue guidance for 2020 in the mid single-digit percentage range and adjusted EBITDA margin of around 21% confirmed - Refinancing of EUR 190m promissory loan maturing in November 2020 secured ahead of time - First quarter level with prior year, as expected: revenues EUR 304m, ...
Duesseldorf (ots) - -Foundation for sustainable and profitable growth laid in 2019: Annual revenue growth in the mid-single-digit percentage range targeted for 2020 and subsequent years -2019 operating targets met: Underlying revenues reach EUR 1.40bn and underlying adjusted EBITDA EUR 293m -Further increase in proposed dividend to EUR 1.20 per share from ...
Düsseldorf (ots) - - Revenues up 1.4 % on the prior-year quarter to EUR 358.6m - Adjusted EBITDA at EUR 72.2m in third quarter of 2019 - Adjusted net income at EUR 30.7m in third quarter of 2019 - New innovation center for pharmaceutical glass opened in the US - Successful refinancing by a EUR 550.0m ...
Düsseldorf/Vineland, New Jersey (ots) - Gerresheimer is driving innovation in pharmaceutical glass, primary packaging glass products, technologies and digitized processes. In the future, highly qualified engineers at the recently opened "Gx Glass Innovation and Technology Center" will develop innovative ...
Duesseldorf (ots) - - Revenues up 7.2% on the prior-year quarter to EUR 356.5m - Adjusted EBITDA at EUR 74.2m in second quarter of 2019 (Q2 2018: EUR 71.1m), excluding EUR 26.2m from derecognition of contingent purchase price components in connection with Sensile Medical acquisition - Revenue guidance confirmed without change; guidance on adjusted EBITDA at ...
Düsseldorf (ots) - Dr. Bernd Metzner (48) takes up the position of Chief Financial Officer of Gerresheimer AG on May 15, 2019. Dr. Metzner had been Chief Financial Officer of SDAX-listed Ströer SE & Co. KGaA since 2014. "I very much welcome the financial expertise and years of industry experience that ...
Duesseldorf (ots) - - Revenues up 6.3% on the prior-year quarter to EUR 308.5m - Adjusted EBITDA at EUR 145.9m in first quarter of 2019 (Q1 2018: EUR 52.6m), comprising of EUR 53.6m plus EUR 92.3m from partial derecognition of contingent purchase price components connected to the Sensile Medical acquisition - Guidance for adjusted EBITDA at constant ...
Duesseldorf/Skopje (North Macedonia) (ots) - Gerresheimer AG is to build a new plant in Skopje, Republic of North Macedonia. "As part of our growth strategy, we require additional manufacturing capacity and are expanding our European production ...
Duesseldorf (ots) - - Revenues at constant exchange rates up 4.3% in the financial year 2018 to EUR 1,406.7m - Adjusted EBITDA at constant exchange rates at EUR 307.5m, excluding the Advanced Technologies Division and other one-off effects, and despite substantially negative energy costs and resin prices - Strong adjusted net income after non-controlling ...
Düsseldorf (ots) - Dr. Bernd Metzner (48) is to become Chief Financial Officer of Gerresheimer AG, taking up office at the latest on July 1, 2019. Dr. Bernd Metzner has been Chief Financial Officer of SDAX-listed Ströer SE & Co. KGaA since 2014. "In Dr. Bernd Metzner, we have gained a highly ...
Düsseldorf (ots) - - Revenues at constant exchange rates up 8.8% in third quarter of 2018 to EUR 364.4m - Adjusted EBITDA at constant exchange rates - excluding Sensile Medical and negative effects relating to the exemption from electricity network charges - increased by EUR 1.3m in third quarter to EUR ...
Düsseldorf (ots) - Andreas Schütte (56) will step down from the Management Board of Gerresheimer AG at his own request as of February 28, 2019 in order to pursue new career challenges. The Supervisory Board of Gerresheimer AG approved this wish at its meeting yesterday. Andreas Schütte has served on ...
Duesseldorf/Olten (ots) - A wearable micro pump from Sensile Medical has received EU certification for the European market. A European pharma company has obtained a CE declaration of conformity for the pump, which is specially designed for the ...
Duesseldorf (ots) - - Dietmar Siemssen to assume as Chief Executive Officer on November 1, 2018 - Previously held position as Stabilus CEO - Speaker of the Management Board and CFO Rainer Beaujean will not extend contract after April 30, 2019 Dietmar Siemssen (55) will join the Management Board of Gerresheimer AG as Chief Executive Officer on November 1, ...
Düsseldorf (ots) - - With the acquisition of Sensile Medical, Gerresheimer is extending its business model in the direction of an Original Equipment Manufacturer (OEM) for drug delivery platforms with digital and electronic capabilities for pharmaceutical and biopharmaceutical customers. The purchase ...
